Bancalari EH, Jobe AH. The respiratory course of extremely preterm infants: a dilemma for diagnosis and terminology. J Pediatr. 2012;161:585–8.
Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev. 2009;2:CD007836.
Ho JJ, Henderson-Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2002:CD002975.
Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Cochrane Database Syst Rev 2002:CD003063.
De Klerk AM, De Klerk RK. Nasal continuous positive airway pressure and outcomes of preterm infants. J Paediatr Child Health. 2001;37:161–7.
Gittermann MK, Fusch C, Gittermann AR, Regazzoni BM, Moessinger AC. Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infants. Eur J Pediatr. 1997;156:384–8.
Polin RA, Sahni R. Newer experience with CPAP. Semin Neonatol. 2002;7:379–89.
Dani C. Surfactant treatment threshold during ncpap for the treatment of preterm infants with respiratory distress syndrome. Am J Perinatol. 2016;33:925–9.
Sweet DG, Carnielli VP, Greisen G, Mikko Hallman M, Klebermass-Schrehof K, Ozek E, et al. European consensus guidelines on the management of respiratory distress syndrome: 2022 update. Neonatology. 2023;120:3–23.
Capasso L, Pacella D, Migliaro F, Salomè S, Grasso F, Corsini I, et al. Can lung ultrasound score accurately predict surfactant replacement? A systematic review and meta-analysis of diagnostic test studies-In reply. Pediatr Pulmonol. 2023;58:1427–37.
Corsini I, Lenzi MB, Ciarcià M, Matina F, Petoello E, Flore AI, et al. Comparison among three lung ultrasound scores used to predict the need for surfactant replacement therapy: a retrospective diagnostic accuracy study in a cohort of preterm infants. Eur J Pediatr. 2023;182:5375–83.
Soll R, Ozek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2009;1:CD000141.
Coshal H, Mukerji A, Lemyre B, Ng EH, Alvaro R, Ethier G, Yoon EW, et al. Characteristics and outcomes of preterm neonates according to number of doses of surfactant received. J Perinatol. 2021;41:39–46.
Ferri WAG, da Silva AC, Sacramento EMF, Calixto C, Aragon DC, Caldas JPS. Retreatment with surfactant in very low birth weight preterm infants: risk predictors and their influence on neonatal outcomes. Rev Paul Pediatr. 2020;39:e2019360.
Article PubMed PubMed Central Google Scholar
Lanciotti L, Pasqualini M, Correani A, Burattini I, Giorgetti C, Palazzi ML, et al. Who needs a second dose of exogenous surfactant? J Pediatr. 2023;261:113535.
Cogo PE, Facco M, Simonato M, De Luca D, De Terlizi F, Rizzotti U, et al. Pharmacokinetics and clinical predictors of surfactant redosing in respiratory distress syndrome. Intensive Care Med. 2011;37:510–7.
Greiner E, Wittwer A, Albuisson E, Hascoët JM. Outcome of very premature newborn receiving an early second dose of surfactant for persistent respiratory distress syndrome. Front Pediatr. 2021;9:663697.
Article PubMed PubMed Central Google Scholar
Lista G, Boni L, Scopesi F, Boni L, Agosti M, Biban P, Del Vecchio A, et al. Sustained lung inflation at birth for preterm infants: a randomized clinical trial. Pediatrics. 2015;135:e457–64.
Dani C, Napolitano M, Barone C, Manna A, Nigro G, Scarpelli G, et al. Nasal intermittent positive pressure ventilation during less invasive surfactant administration in preterm infants: an open-label randomized controlled study. Pediatr Pulmonol. 2024;59:1006–14.
Dani C, Cecchi A, Ciarcià M, Miselli F, Luzzati M, Remaschi G, et al. Enteral and parenteral treatment with caffeine for preterm infants in the delivery room: a randomised trial. Paediatr Drugs. 2023;25:79–86.
Dani C, Mosca F, Vento G, Tagliabue P, Picone S, Lista G, et al. Effects of surfactant treatment in late preterm infants with respiratory distress syndrome. J Matern Fetal Neonatal Med. 2018;31:1259–66.
Wyckof MH, Aziz K, Escobedo MB, Kapadia VS, Kattwinkel J, Perlman JM, et al. Part 13: neonatal resuscitation: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care (reprint). Pediatrics. 2015;136:S196–218.
Papile LS, Burstein J, Burstein R, Koffler H. Incidence and evolution of the sub-ependymal intraventricular hemorrhage; a study of infants weighing less than 1500 grams. J Pediatr. 1978;92:529–34.
De Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasounds. Beha Brain Res. 1992;49:1–6.
International Committee for the Classification of Retinopathy of Prematurity. The International classification of retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123:991–9.
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L et al. T. Neonatal necrotizing enterocolitis: Therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1–12.
Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, et al. National Institutes of Child Health and Human Development Neonatal Research Network. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116:1353–60.
Oulton M, Fraser M, Dolphin M, Yoon R, Faulkner G. Quantification of surfactant pool sizes in rabbit lung during perinatal development. J Lipid Res. 1986;27:602–12.
Gluck L, Kulovich MV, Borer RC Jr, Keidel WN. The interpretation and significance of the lecithin–sphingomyelin ratio in amniotic fluid. Am J Obstet Gynecol. 1974;120:142–55.
Torresin M, Zimmermann LJ, Cogo PE, Cavicchioli P, Badon T, Giordano G, et al. Exogenous surfactant kinetics in infant respiratory distress syndrome: a novel method with stable isotopes. Am J Respir Crit Care Med. 2000;161:1584–9.
Carnielli VP, Zimmermann LJI, Hamvas A, Cogo PE. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes. J Perinatol. 2009;29(Suppl 2):S29–37.
Tagliaferro T, Jain D, Vanbuskirk S, Bancalari E, Claure N. Maternal preeclampsia and respiratory outcomes in extremely premature infants. Pediatr Res. 2019;85:693–6.
Chen CM, Wang LF. High-dose vascular endothelial growth factor increases surfactant protein gene expressions in preterm rat lung. Early Hum Dev 3007;83:581–4.
Beauchene MS, Cunningham AM, Stanford AH, Bischoff AR, Dagle JM, Rios DR, et al. Patent ductus arteriosus (PDA) and response to late surfactant treatment in premature infants. J Perinatol. 2023;43:1245–51.
Bruni R, Bunchen RF, David-Cu R, Taeusch HW, Walther FJ. Inactivation of surfactant in rat lungs. Pediatr Res. 1996;39:234–40.
Krafft MP. Overcoming inactivation of the lung surfactant by serum proteins: a potential role for fluorocarbons? Soft Matter. 2015;11:5982–94.
Orgeig S, Crittenden TA, Marchant C, McMillen IC, Morrison JL. Intrauterine growth restriction delays surfactant protein maturation in the sheep fetus. Am J Physiol Lung Cell Mol Physiol. 2010;298:L575–83.
Gagnon R, Langridge J, Inchley K, Murotsuki J, Possmayer F. Changes in surfactant-associated protein mRNA profile in growth-restricted fetal sheep. Am J Physiol. 1999;276:L459–465.
留言 (0)